A symmetric three-class predictor of DrugComb ZIP interactions was developed and compared all seven combinations of landmark expression, Hallmark pathway scores and CollecTRI regulon activities, demonstrating that the predictive value of functional context representations depends on both the type of domain shift and the evaluation objective.
Abstract
Drug combination models must represent cellular context in a form that remains informative when the tested cells or compounds differ from those used for training. Transcription factor regulons offer a biologically structured representation, but their contribution can depend on the accompanying features and the intended prediction task. We developed a symmetric three-class predictor of DrugComb ZIP interactions and compared all seven combinations of landmark expression, Hallmark pathway scores and CollecTRI regulon activities. The common dataset contained 302,042 observations across 3,042 drugs and 155 cellular contexts. We evaluated three group-held-out generalization settings: unseen cell lines, unseen drug scaffolds, and simultaneous exclusion of both, with five training seeds per representation and partition. Pathways plus regulons achieved the highest mean Macro-F1 on unseen cell lines (0.4737, compared with 0.4503 for expression alone). Compared with pathways alone, adding regulons increased mean Macro-F1 by 0.0153 on unseen cell lines and 0.0229 on unseen drug scaffolds, with positive differences across all five paired seeds in both settings. In contrast, the same addition reduced the mean under joint context and scaffold exclusion. Representation rankings also depended on the objective: regulons alone achieved the highest synergy average precision on unseen lines, whereas the Macro-F1-leading combination did not maximize precision among the top-ranked candidates. Further compression of pathways into non-negative matrix factorization programs did not exceed the best context-model Macro-F1 in any setting. These results demonstrate that the predictive value of functional context representations depends on both the type of domain shift and the evaluation objective, and that combining additional biological representations does not necessarily improve generalization. They provide a computational basis for studying drug combinations in senescent states, where transfer must subsequently be assessed using state-specific responses and matched controls.
Cells are characterized by molecular states, coordinated molecular interactions, regulatory programs, and responses to perturbations. Systematic mapping of these cellular functional profiles across biological contexts remains experimentally costly and fragmented. Here we present InsilicoCell, a pretrained multi-modal,...
Ruoqiao Chen, Li Huang, Yu Qiao et al.· bioRxiv· 0 citations
An artificial intelligence framework that integrates biological mechanism knowledge to predict how cells respond to chemical perturbation, improving generalization to untested drugs and prioritizing cancer drug candidates in virtual screening is introduced.
Accurate prediction of cancer cell responses to chemical compounds remains a fundamental challenge in precision oncology and drug discovery. Although several drug response prediction (DRP) models have been proposed, most were evaluated using random splits of drug-cell line pairs, allowing the same drugs to appear in bo...
Ji-Sang Lee, Taelim Yeom, June-Woo Kim et al.· IEEE journal of biomedical a...· 0 citations
Joint training of matched drug contrasts turn complementary screens into shared molecular supervision for unseen-drug response prediction while preserving native gene measurements, demonstrating how matched drug contrasts can coexist with weak prediction of drug-specific differences.
Yun-Fan Liu, Kasra Ghorbani, Yu-Fei Huang et al.· 0 citations
Accurately predicting cellular responses to drugs remains a challenge with the potential to reduce experimental screening costs and accelerate drug discovery. Current computational approaches represent compounds through chemical structures, which carry little information regarding their activity within biological syste...
Léa Kaufmann, Lola Le Breton, E. Carraz-Billat et al.· bioRxiv· 0 citations
Case studies further validated predicted circRNA-drug associations, including cisplatin, enzalutamide, and sorafenib, against published experimental findings, demonstrating HMCDSP's capacity to reveal clinically relevant biomarkers and inform personalized therapeutic strategies.
Yong-Tian Wang, Wen-Kai Shen, Jiahao Li et al.· Interdisciplinary Sciences C...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.